Post-Operative Nausea And Vomiting Study In Female Patients

Completed · Phase 2

Conditions studied: Postoperative Nausea and Vomiting, Nausea and Vomiting, Postoperative

In brief

The primary purpose of this study is to determine an effective dose of this NK-1 anti-emetic medication to prevent nausea and vomiting in females after surgery.

Key facts

Study ID

NCT00274690

Run by

GlaxoSmithKline

People needed

435

Starts

2005-02-01

Expected to finish

2005-08-01

Last updated by the study team

2017-01-20

Who can join

Age: 18 and older, up to 55. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Known, specified risk factors for PONV (post operative nausea and vomiting)
• Undergoing gynecologic or gallbladder surgery.

You may not qualify if…

• pregnant or breastfeeding
• post-menopausal

Where it is running

• GSK Investigational Site — San Francisco, California, United States
• GSK Investigational Site — Melbourne, Florida, United States
• GSK Investigational Site — West Palm Beach, Florida, United States
• GSK Investigational Site — Chicago, Illinois, United States
• GSK Investigational Site — Grand Rapids, Michigan, United States
• GSK Investigational Site — Royal Oak, Michigan, United States
• GSK Investigational Site — Camden, New Jersey, United States
• GSK Investigational Site — Winston-Salem, North Carolina, United States
• GSK Investigational Site — Dallas, Texas, United States
• GSK Investigational Site — San Antonio, Texas, United States
• GSK Investigational Site — Seattle, Washington, United States
• GSK Investigational Site — Copenhagen, Denmark
• GSK Investigational Site — Glostrup Municipality, Denmark
• GSK Investigational Site — Viborg, Denmark
• GSK Investigational Site — Lai Chi Kok, Hong Kong
• GSK Investigational Site — Pokfulam, Hong Kong
• GSK Investigational Site — Shamshuipo, Kowloon, Hong Kong
• GSK Investigational Site — Shatin, New Territories, Hong Kong
• GSK Investigational Site — Tuenmen, Hong Kong
• GSK Investigational Site — Budapest, Hungary
• GSK Investigational Site — Budapest, Hungary
• GSK Investigational Site — Szentes, Hungary
• GSK Investigational Site — Kfar Saba, Israel
• GSK Investigational Site — Tel Litwinsky, Israel
• GSK Investigational Site — Gjettum, Norway

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.